MARKET WIRE NEWS
  1. Home
  2. Stock
  3. INKT
  4. News
INKT
Quote
Short
News
Articles
Message Board

MiNK Therapeutics Inc. (NASDAQ : INKT ) News

MiNK Therapeutics Inc. (NASDAQ: INKT) News Releases

INKT News Releases
INKT : NASDAQ
GlobeNewswire
MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting
INKT : NASDAQ
GlobeNewswire
MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
INKT : NASDAQ
GlobeNewswire
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
INKT : NASDAQ
SeekingAlpha
MiNK outlines 90-patient randomized Phase II ARDS trial with initial data expected in 2H 2026
INKT : NASDAQ
SeekingAlpha
MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call Transcript
INKT : NASDAQ
Motley Fool
MiNK (INKT) Q4 2025 Earnings Call Transcript
INKT : NASDAQ
Motley Fool
MiNK (INKT) Q1 2026 Earnings Call Transcript
INKT : NASDAQ
SeekingAlpha
MiNK Therapeutics GAAP EPS of -$0.57 beats by $0.20
INKT : NASDAQ
GlobeNewswire
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
INKT : NASDAQ
US Earnings Reports
Expected US Company Earnings on Friday, May 15th, 2026
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.